New Therapeutic Horizons for Advanced or Metastatic Penile Cancer

This publication has 66 references indexed in Scilit:

• The role of Her-2 in penile squamous cell carcinoma progression and cisplatin chemoresistance and potential for antibody-drug conjugate-based therapy
  European Journal of Cancer, 2023
• Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune‐checkpoint inhibitor‐related biomarkers
  Cancer, 2023
• Penile cancer: Updates in systemic therapy
  Asian Journal of Urology, 2022
• 715P Nivolumab in pretreated metastatic penile squamous cell carcinoma: Results of the penile cohort from the French AcSé prospective program
  Annals of Oncology, 2021
• The International Penile Advanced Cancer Trial (InPACT): Rationale and Current Status
  European Urology Focus, 2019
• Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16–Related Cancer
  JAMA Oncology, 2019
• Panitumumab Treatment for Advanced Penile Squamous Cell Carcinoma When Surgery and Chemotherapy Have Failed
  Clinical Genitourinary Cancer, 2016
• Paclitaxel in Pretreated Metastatic Penile Cancer: Final Results of a Phase 2 Study
  European Urology, 2011
• Neoadjuvant Chemotherapy in Advanced Penile Carcinoma
  European Urology, 2007
• Prognostic factors in node-positive carcinoma of the penis
  Journal of Surgical Oncology, 2006